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The  aquaporins  (AQPs)  are  a  superfamily  of  major
intrinsic proteins of ~30 kDa, expressed in both prokaryotes
and  eukaryotes.  In  mammals,  thirteen  AQPs  have  been
identified.  As  in  several  other  organs,  water  conductance
across the many membrane barriers in the eye is assisted by
these proteins. Seven AQPs are expressed in the various parts
of the eye; three each are present in the mammalian cornea
(AQP1, AQP3, AQP5) and lens (AQP0, AQP1, AQP5).
Cornea  and  lens  are  avascular  tissues  with  unique
microcirculatory  mechanisms  that  are  assisted  by  water
channels, for meeting the nutritional demands and removing
the metabolic byproducts. In the cornea, the outer stratified
epithelium expresses AQP5 and AQP3, stromal keratocytes
express AQP1, and the single-celled inner endothelial layer
expresses  AQP1  and  AQP3  [1-3].  In  the  lens,  anterior
epithelial cells have AQP1 [3], which functions as a water
channel [4,5]. Lens fiber cells abundantly express AQP0 [6]
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which performs water conductance [4,7], as well as a unique
function of cell-to-cell adhesion [8,9].
AQPs contain two tandem repeats (Figure 1), possibly
due to gene duplication during evolution. The transmembrane
topology of AQP5 shows six membrane-spanning α-helices
(H1-H6),  and  five  loops  (A-E)  that  connect  the
transmembrane domains. Loops B and E act as hemichannels
and together form an 'hourglass' structure for water flow; each
loop contains a highly conserved, asparagine–proline–alanine
(NPA) motif, which is critical for water permeation. Two
putative phosphorylation sites [10,11] are present as indicated
in Figure 1.
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Purpose: Aquaporins (AQPs) play a significant role in the movement of water across the plasma membrane. In the eye,
the cornea and lens are avascular with unique microcirculatory mechanisms to meet the metabolic demands. We have
previously shown that AQP0 and AQP1 water channels participate in maintaining lens transparency and homeostasis. In
the present investigation, we explored the expression and spatial distribution of AQP5 in the cornea and lens, and its
regulation during membrane localization.
Methods: AQP5 expression and cellular localization were investigated by reverse transcription polymerase chain reaction
(RT-PCR) using gene-specific primers, and by western blot and immunocytochemistry analyses using specific antibodies.
AQP5  phosphorylation  was  studied  using  calf  intestinal  alkaline  phosphatase  for  dephosphorylation.  Effects  of
phosphokinase A (PKA) agonist cyclic AMP (cAMP), and antagonist H-89 on AQP5 expression and localization were
studied in vitro using MDCK (Madin-Darby Canine Kidney) cells, and ex vivo using isolated corneas from wild type
mice.
Results: RT–PCR revealed the presence of AQP5 transcripts in the cornea, lens epithelial cells and fiber cells. Western
blotting identified the presence of both non-phosphorylated and phosphorylated forms of AQP5 protein. Immunostaining
showed the distribution of AQP5 in the epithelial layer and stromal keratocytes of the cornea, and epithelial and fiber cells
of the lens. In vitro and ex-vivo experiments revealed PKA-induced AQP5 internalization; PKA inhibition prevented such
internalization.
Conclusions: This is the first report on the spatial expression of AQP5 in the corneal keratocytes and lens epithelial cells,
as well as on the regulation of AQP5 localization by PKA in the corneal epithelial cells. PKA-mediated regulation of
AQP5 holds promise for therapeutic intervention to control corneal and lens diseases.
AQP5 is expressed in a wide range of tissues. It is found
in lung pneumocyte type I cells [12], granules of Brunner
glands in the duodenum [13], in the uterus [14], salivary gland
[10,15,16], lacrimal gland [17,18], pancreas [19,20], cornea
[1,2,18,21,22], lens [1,23,24], and retina [25,26]. The level of
expression is higher in the secretory tissues and glands than
in the non-secretory cells. AQP5 plays a significant role in the
production of saliva, pulmonary secretions, and tears. After
the  cloning  of  AQP5  from  rat  submandibular  gland  [10],
studies conducted using AQP5 knockout mouse (AQP5-KO)
model have corroborated that AQP5 plays an important rolein salivary secretion  [27,28]  and  corneal  thickness  [29].
However, tear secretion was not altered in the AQP5-KO
mouse [30,31].
The presence of AQP5 transcripts in the cornea [1] and
lens [1,32], and AQP5 protein in the cornea [2,18,22] and lens
fiber cells [23,24] has been documented. Patil et al. [1] used
reverse transcription polymerase chain reaction (RT-PCR),
and Wistow et al. [32] followed expressed sequence tag (EST)
analysis to explore the presence of AQP5 transcripts in the
lens. Immunocytochemical studies [2,18,22] identified the
presence of AQP5 only in the epithelial cells of the cornea.
Several other studies of AQP5 protein in the lens used mass
spectrometric analysis [23,24], that helps to determine the
presence of a particular protein in a sample but does not
provide  any  information  on  its  spatial  distribution.  Even
though the presence of AQP5 protein in the cornea and lens
has been identified, there has been no investigation yet to show
whether it is expressed overall in these tissues or in specific
regions. In the present study, we investigated in detail the
expression of AQP5 and its regulation in the cornea and/or
lens. Our results showed the presence of AQP5 in the corneal
epithelial cells, stromal keratocytes, and in the epithelial and
fiber  cells  of  the  lens.  The  study  further  identified  that
regulating AQP5 by manipulating phosphorylation could be
a tool for therapeutic intervention to control corneal and lens
diseases.
METHODS
Animals: Wild type (WT; C57BL/6) and AQP5 knockout
(AQP5-KO [33]) mice, and New Zealand white rabbits were
used. Eyes were enucleated and transferred to mammalian
physiological saline. Corneas and lenses were dissected out
under  a  microscope.  All  experimental  and  animal  care
procedures  were  performed  according  to  the  ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research, and were approved by the State University of New
York  at  Stony  Book  Institutional  Animal  Care  and  Use
Committee.
RT-PCR, cloning and sequencing: Total RNA was extracted
separately from mouse lacrimal gland, whole cornea, and lens
anterior epithelial cells and fiber cells, using RNA STAT-60
(TEL-TEST  Inc.,  Friendswood,  TX).  Following  the
manufacturer's instructions [5], RT-PCR was carried out in a
Gradient Thermal Cycler (Stratagene) using AQP5-, AQP0-,
or AQP1-specific primers (Table 1) and the products were
fractionated  on  1.2%  agarose  gels,  stained  with  ethidium
bromide and viewed over UV. Images were captured and
digitized using Kodak Image Station [34]. cDNAs amplified
from  epithelial  and  fiber  RNAs  were  cloned  between  the
EcoRI and BamHI restriction sites of pIRES2-EGFP vector
(Clontech, Mountain View, CA). Transformation was carried
out using MAX Efficiency® DH5α™ E. coli competent cells
(Invitrogen, Life Technologies, Grand Island, NY). Positive
clones  were  selected  using  kanamycin-Luria-Bertani  (LB)
agar plates. Sequences of extracted DNAs were verified by
Figure 1. Schematic diagram of mouse
AQP5 transmembrane topology. NPA
(blue  circles)  represents  the  highly
conserved  aquaporin  signature
sequence. H1–H6, membrane-spanning
helices; A–E, loops; loops B and E form
pore helices. NH2- and COOH- amino
and  carboxyl  terminal  domains,
respectively.  Two  consensus
phosphorylation motifs are present, one
at amino acid residues RRTSP at 153–
157 in loop D and another, RKKT at
256–259 at the COOH-terminal domain.
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958automated  sequencing  using  fluorescent  dye  terminators
(Stony Brook University, DNA Sequencing Facility, Stony
Brook, NY).
Western blotting, dephosphorylation, and immunostaining:
Total membrane proteins extracted from whole cornea and
lens of rabbit and mouse, as well as from mouse lacrimal gland
(positive control) and different regions of lens [4] were used
for western blotting [34,35]. In short, cornea, lens epithelium,
lens cortex and lens nucleus were dissected out under ice-cold
physiological saline. Tissues were homogenized using 1× gel
loading buffer (Invitrogen, Life Technologies) in 25 mM Tris-
HCl (pH 7.2) with proteinase inhibitor cocktail (Sigma) and/
or phosphatase inhibitor ( Roche Diagnostics Corporation,
Indianapolis, IN). The homogenates were spun at 45,000× g
for 30 min and the membrane pellets were washed two times
with the homogenizing buffer. The membrane pellets were
homogenized in 50–100 μl of protein extraction buffer (2%
SDS)  and  sonicated  for  1  min  with  short  bursts.  The
homogenates were centrifuged at 12,000× g for 30 min, and
the  supernatants  were  mixed  with  NuPAGE  LDS  sample
buffer  (Invitrogen)  and  fractionated  using  10%  NuPAGE
Novex Bis-Tris gel with MOPS-SDS as the running buffer
(Invitrogen).  Proteins  from  the  denaturing  gels  were
transferred  to  PVDF  nylon  membranes  and  exposed  to
COOH-terminal-specific  anti-AQP5,  anti-AQP1  or  anti-
AQP0 antibodies (Chemicon, Billerica, MA or Santa Cruz
Biotechnology, Inc., Santa Cruz, CA) as appropriate. Alkaline
phosphatase conjugated secondary antibodies were used and
detection of antibody binding was carried out using alkaline
phosphatase detection kit (Vector Laboratories, Burlingame,
CA).
In  dephosphorylation  studies,  calf  intestinal  alkaline
phosphatase  (25  units)  was  added  to  ~25  μg  of  purified
membrane protein samples and incubated for 60 min at 37 °C.
Reactions were stopped with 50 mM EDTA and analyzed by
western blotting as described above [34].
To investigate the spatial expression of different AQPs,
eyes  of  WT  and  AQP5-KO  mice  were  fixed  in  4%
paraformaldehyde, cryosectioned, and immunostained with
anti-AQP5  (Chemicon,  Billerica,  MA  or  Epitomics,  Inc.,
Burlingame,  CA),  anti-AQP1  or  anti-AQP0  antibodies  as
appropriate, and imaged using a Zeiss confocal microscope as
described [5]. Briefly, cornea and in vitro culture cells were
fixed in 4% paraformaldehyde in phosphate-buffered saline
(PBS) for 30 min; lenses were fixed for 12 h. Fixed corneas
and lenses were cryoprotected, and sectioned at 10-16 μm
thickness using a cryomicrotome (Leica) and stored at −20 °C.
Cryosections,  and  fixed  culture  cells  were  permeabilized
(0.2% [v/v] Triton X-100) for 20 min at room temperature,
blocked  with  normal  goat  serum  and  treated  with  rabbit
polyclonal antibody raised against AQP5, AQP0, or AQP1, at
a dilution of 1:200 with 5% (w/v) bovine serum albumin
(BSA) in PBS. After overnight incubation and three washes
in  PBS,  the  slides  were  exposed  to  fluorescein  5′-
isothiocyanate (FITC) or Texas Red conjugated goat anti-
rabbit IgG in PBS containing 5% BSA. The slides with the
treated tissue sections or cells were washed again in PBS,
mounted  in  anti-fade  Vectamount  (Vector  Laboratories,
Burlingame, CA) containing nuclear stain DAPI and viewed.
Optimized  Z-sectional  digital  images  were  acquired  and
deconvolved  using  Zeiss  AxioVision  software  Version  5.
Representative images are given.
Effects of cAMP and H-89 on AQP5 expression, trafficking,
and localization: Mouse AQP5 expression construct (AQP5-
pIRES2-EGFP) was transfected into Madin Darby Canine
Kidney (MDCK) cells. MDCK cells were used for in vitro
studies  on  AQP5  expression,  trafficking,  and  localization
because these cells do not express AQP5 and are epithelial
cells, like the corneal and lens epithelial cells with apical and
basolateral  sides.  In  short,  MDCK  cells  (American  Type
Culture Collection, Manassas, VA) were grown in Minimum
Essential  Medium  (Invitrogen,  Life  Technologies,  Grand
Island, NY) that was supplemented with 5% heat-inactivated
fetal calf serum (Hyclone Laboratories, Inc., UT) and 100 U/
ml penicillin and 0.1 mg/ml streptomycin. Cell cultures were
maintained  at  37  °C,  under  5%  CO2  in  a  humidified
atmosphere. Transfections were carried out using Effectene
reagent  (Qiagen),  following  the  manufacturer's
recommendations.  Stable  cell  lines  were  selected  using
Geneticin® (G418; A.G. Scientific, Inc., CA) Sulfate (400
mg/ml media).
Stable  cells  expressing  AQP5  were  exposed  to  PKA
agonist mp-cAMP (membrane permeable cyclic AMP, 100
mM; Sigma-Aldrich, St. Louis, MO) or PKA antagonist H-89
(20 mM; Sigma-Aldrich) for 30 min. In another experiment,
cells were incubated first with the H-89 for 30 min, and then
TABLE 1. PRIMERS USED FOR RT-PCR.
Gene Accession # Primer Sequence
AQP5 BC150769 Forward 5'-ATGAAGAAGGAGGTGTGTTCAG-3'
AQP5 BC150769 Reverse 5'-TCAGTGTGCCGTCAGCTCGATGGTC-3'
AQP0 NM008600 Forward 5'-ATGTGGGAACTTCGGTCTGCCTC-3'
AQP0 NM008600 Reverse 5'-TTACAGGGCCTGAGTCTTCAGTTC-3'
AQP1 BC007125.1 Forward 5'-ATGGCCAGTGAAATCAAGAAG-3'
AQP1 BC007125.1 Reverse 5'-CTATTTGGGCTTCATCTCCAC-3'
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959stimulated with mp-cAMP for the same duration. Cells were
washed  in  PBS,  fixed  in  4%  paraformaldehyde  and
immunostained using anti-AQP5 antibody as described above
[34].
For  ex  vivo  investigation,  WT  mouse  corneas  were
incubated  in  Minimum  Essential  Medium  with  2%  fetal
bovine serum containing the PKA agonist or antagonist for 30
min  or  6  h.  Corneas  were  washed  with  PBS,  fixed,
cryosectioned, and immunostained using anti-AQP5 antibody
as described above [5].
Figure 2. Reverse-transcription polymerase chain reaction (RT–PCR) analysis of AQP5. A: In mouse lens. Lanes: 1 Wild type (WT) lacrimal
gland (positive control), 2. AQP5 knockout (AQP5-KO) lacrimal gland, 3. WT cornea, 4. WT cornea + RNase, 5. AQP5-KO cornea, 6. WT
lens epithelium, 7. AQP5-KO lens epithelium, 8. WT lens epithelium + RNase, 9. WT lens cortex, 10. WT lens cortex + RNase, 11. AQP5-
KO lens cortex, MW-Molecular weight marker. B: RT–PCR analysis of AQP1 in mouse lens epithelial cells. Lanes: 1. WT lens epithelium,
2.WT lens epithelium + RNase, 3. AQP5-KO lens epithelium, 4. AQP5-KO lens epithelium + RNase, MW-Molecular weight marker. C: RT–
PCR analysis of AQP0 in mouse lens fiber cells. Lanes: 1. WT lens cortex, 2. WT lens cortex + RNase, 3. AQP5-KO lens cortex, 4. AQP5-
KO lens cortex + RNase, MW-molecular weight marker.
Figure  3.  Immunoblot  analyses  of
corneal and lens membrane proteins to
identify  the  expression  of  AQP5.  A:
From rabbit: Lanes; 1. total cornea, 2.
total  lens.  B:  From  mouse:  Lanes:  1.
lacrimal  gland  (+ve  control),  2.  total
cornea, 3. total lens, 4. lens epithelial
cell membrane, 5. lens cortex fiber cell
membrane,  6.  lens  nuclear  fiber  cell
membrane.  C:  AQP5-KO  mouse  lens
fiber cell membrane proteins. Lanes: 1.
AQP0,  2.  AQP5,  expressions  studied
using  anti-AQP0  and  anti-AQP5
antibodies,  respectively.  D:
Immunoblot  of  dephosphorylation
studies  in  WT  corneal  membrane
proteins  using  anti-AQP5  antibody.
Lanes: 1. WT untreated proteins (arrow
- ~28 kDa; arrowhead - ~34 kDa), 2. WT
proteins  treated  with  calf  intestinal
alkaline phosphatase; the 34 kDa band
disappeared,  presumably  due  to
dephosphorylation.
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960RESULTS AND DISCUSSION
Expression of AQP5 transcripts in the mouse cornea and lens:
Total RNA samples from the WT and AQP5-KO mice were
subjected to RT–PCR to determine the expression of AQP5,
AQP1, or AQP0 using gene-specific primers (Table 1), at the
message  level.  Figure  2A  shows  the  amplification  of  an
approximately ~0.8 kb DNA segment from the WT lacrimal
gland (positive control), cornea, lens epithelium, and lens
cortical fiber cell samples (lanes 1, 3, 6, and 9, respectively).
As expected, comparable samples of the AQP5-KO mouse
(lanes  2,  5,  7,  and  11,  respectively)  did  not  show  any
amplification.  AQP5  genomic  DNA  sequence  has  three
introns and four exons. The total RNAs prepared were not
contaminated with the genomic DNA, since the RT–PCR-
amplified products showed a single band of ~0.8 kb (Figure
2A, lanes 1, 3, 6, and 9) comparable to the PCR product of
cloned AQP5 cDNA (798 bp; not shown). In addition, there
was no amplification from the RNase I treated WT RNAs
(Figure 2A, lanes 4, 8, and 10). To confirm that the transcripts
were those of AQP5, we cloned and sequenced the RT–PCR
products of mouse lens epithelial cells, and fiber cells. FASTA
analyses  showed  100%  homology  to  the  mouse  AQP5
sequence  in  the  GenBank  (BC150769)  verifying  the
authenticity of the identified AQP5 transcripts.
Figure 2B shows the expression of AQP1 transcripts in
the epithelial cells of WT and AQP5-KO mice (lanes 1 and 3)
and their absence in the RNase-treated samples (lanes 2 and
4). Similarly, AQP0 transcripts were present in the lens fiber
cells of WT and AQP5-KO mice (Figure 2C, lanes 1 and 3),
and were not seen when treated with RNase (lanes 2 and 4).
In summary, RT–PCR data for lens revealed the presence of
AQP5 and AQP1 transcripts in the epithelial cells and AQP5
and AQP0 transcripts in the fiber cells.
Expression of AQP5 protein in the cornea and lens: The
presence of AQP5 expression at the message level in mouse
cornea and lens prompted us to find out whether there is
expression at the protein level. Information about the cellular
and subcellular localization of AQP5 protein is critical for
understanding the role of AQP5 in these tissues. Therefore,
we performed western blotting and immunostaining.
Total membrane proteins from rabbit cornea and lens
were immunoblotted with anti-AQP5 antibody (Figure 3A,
lanes 1 and 2) which bound to two bands of ~28 (arrow) and
~34 kDa (arrowhead). Similar binding occurred with samples
of mouse lacrimal gland (positive control; Figure 3B, lane 1),
cornea (lane 2), lens (lane 3) and distinct regions of the lens
(lanes 4–6). Total membrane proteins from AQP5-KO mouse
lens immunoblotted with anti-AQP0 (Figure 3C, lane 1) and
anti-AQP5 (Figure 3C, lane 2) antibodies separately, showed
the  expression  of  AQP0  and  the  absence  of  AQP5,
respectively, substantiating the reaction specificity. In Figure
3A, the ~28 kDa band (arrow) corresponds to the unmodified
AQP5 while the ~34 kDa band (arrowhead) could be due to
post-translational  modification  such  as  phosphorylation.
AQP5  has  two  consensus  PKA/PKG-activated
phosphorylation motifs (Figure 1), one at residues 153–157
(RRTSP)  in  loop  D,  and  the  second  at  residues  256–259
(RKKT) at the COOH-terminal domain. To test whether the
34 kDa band could be a phosphorylation product, we treated
mouse corneal membrane proteins (Figure 3D, lane 1) with
calf  intestinal  alkaline  phosphatase.  The  ~34  kDa  band
disappeared  (Figure  3D,  lane  2)  presumably,  due  to
dephosphorylation.
To date, AQP1 in the epithelial cells and AQP0 in the
fiber cells, have been functionally characterized in vitro using
Xenopus oocytes and ex vivo using lens epithelial cells and
fiber  cell  vesicles  [4,5,9,34,36-38].  Published  data  on  the
expression of AQP5, in the lens are conflicting. Trace amounts
of AQP5 transcript had been documented for rat [1] and dog
[39] lens tissues. However, immunoblotting of rabbit [40] and
dog [39] lens fiber cell membrane proteins did not detect
AQP5. Mass spectrometry studies showed the presence of
AQP5 among bovine [23] and murine [24] total fiber cell
membrane  proteins.  We  performed  immunocytochemical
studies to distinctly define the presence and localization of
AQP5 within the specific regions of mouse cornea and lens.
Most mammalian corneas have five layers (Figure 4A)
from  anterior  to  posterior  [41,42]:  corneal  epithelium,
bowman's  layer,  stroma,  descemet's  membrane,  and
endothelium. AQP5 expression and localization have been
reported only for the epithelial cell layer and not for other
corneal cell layers in the WT mouse [43], rat [22] and dog
[39]. Figure 4B shows that in the mouse cornea, AQP5 is
expressed in the outermost multilayered epithelial cells, single
layered basal columnar epithelium (abundant expression) and
in the suprabasal cells. Low level expression is seen in the
multilayered flat polygonal cells. Figure 4C corroborates the
specificity  of  antibody  binding  by  the  lack  of
immunoreactivity in the AQP5 knockout mouse cornea. In the
stroma, AQP5 is expressed at low levels in keratocytes close
to Bowman’s membrane in the central cornea (Figure 4B), and
at high levels in keratocytes at the limbal area (Figure 4D and
E) which is the junction of the cornea and the conjunctiva.
There is no expression of AQP5 in the other parts of the cornea
including  the  endothelial  cells.  Immunostaining  of
cryosections  of  AQP5  knockout  limbal  area  (Figure  4F)
showed  no  antibody  binding,  validating  the  specificity  of
immunoreactions in the WT cornea.
AQP5 in the corneal epithelial cells and keratocytes could
be involved in preventing corneal dehydration, promoting
wound healing and maintaining corneal transparency. AQP5-
KO mice showed significant reduction in corneal epithelial
cell membrane water permeability (~2 fold) and increase in
corneal thickness [29]. When corneal epithelial cells were
subjected  to  hypotonic  conditions,  the  recovery  rate  after
swelling was significantly reduced in AQP5-KO compared to
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961Figure 4. Immunolocalization of AQP5 in mouse cornea. A: Schematic diagram of a mammalian cornea showing the five layers. B: AQP5
localization (green) in central corneal epithelial cells and stromal keratocytes. C: AQP5 knockout mouse central corneal epithelial cells and
stromal keratocytes showing lack of immunoreactivity. D: AQP5 localization (red) in the limbal area of the cornea; the window in D is enlarged
and shown as E. E: AQP5 (red) in limbal stromal keratocytes. F: AQP5 knockout mouse corneal stromal keratocytes in the limbal area with
no immunoreactivity. B, C: FITC conjugated secondary antibody. D, E, F: Texas Red conjugated secondary antibody; blue, nuclear stain
DAPI. Epi: epithelium; Str: stroma; En: endothelium; arrows- antibody binding.
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962Figure 5. Immunolocalization of AQP5
protein  in  comparison  with  AQP1  or
AQP0  in  mouse  lens.  A:  AQP1
expression  in  the  WT  lens  anterior
epithelial  cells;  a  window  of  anterior
epithelial cells is enlarged and shown
below,  in  the  same  figure.  B:  AQP5
expression  in  the  WT  lens  epithelial
cells.  C:  (negative  control),  AQP5
knockout mouse lens section showing
lack  of  immunoreactivity  in  the
epithelial cells. D: WT lens outer cortex
fiber  cells  with  AQP5  expression.  E:
WT lens inner cortex fiber cells with
AQP5 expression. F: AQP0 expression
in the lens inner cortex fiber cells (very
intense immunoreactivity compared to
AQP5 expression shown in E). G: WT
lens equatorial region showing AQP5 in
the  epithelial  and  fiber  cells.  H:  The
window  shown  in  G  is  enlarged  to
provide  a  clear  view  of  anti-AQP5
antibody binding to the narrow end of
the  fiber  cells.  I,  J:  AQP5  knockout
mouse  lens  sections  showing  lack  of
immunoreactivity  in  the  cells  at  the
equatorial  and  anterior  regions,
respectively.  A-J:  FITC  conjugated
secondary  antibody;  green,  antibody
binding  indicating  AQP  expression;
blue, nuclear stain DAPI. White arrows
–  antibody  binding.  Yellow  arrows  –
narrow side of the fiber cell; Red arrows
– broader side of the fiber cell; A-C and
G-J  Sagittal  sections;  D-F:  Cross
sections.
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963the WT mice [29]. The corneal epithelial layer serves as a
barrier against pathogenic invasion and helps to keep the
cornea moist. In the epithelial cells, AQP5 may be critical for
corneal fluid dynamics; malfunction can cause corneal edema
and dry eye disease [43,44]. Corneal edema can lead to loss
of transparency. Kenney et al. [45] analyzed AQPs in normal,
diseased  and  cataract-post-surgical  corneas  and  observed
AQP  expression  abnormalities  under  several  disease
conditions.
In  the  WT  lens  epithelial  cells,  anti-AQP1  antibody
bound more intensely to the basolateral side than to the apical
side (Figure 5A) while anti-AQP5 antibody bound uniformly
throughout with punctate membrane localization (Figure 5B).
In AQP5-KO mouse, there was no antibody binding to the
epithelial cells (Figure 5C), substantiating the specificity of
anti-AQP5 antibody binding in the WT (Figure 5B). Figures
5D and E exhibit the expression of AQP5 in the outer cortex
and  inner  cortex  fiber  cells,  respectively.  In  Figure  5D,
antibody binding is more intense on the narrow sides (yellow
arrows)  of  the  fiber  cells  than  on  the  broader  sides  (red
arrows).  In  addition,  it  is  apparent  that  the  intensity  of
antibody binding gradually decreases as the fiber cells run
deep  toward  the  nucleus  of  the  lens.  This  difference  in
antibody binding could be due to epitope masking or loss of
epitopes  due  to  fiber  cell  aging  when  the  cells  lose  their
COOH-terminal  ends;  the  antibodies  tested  were  raised
against  COOH-terminal  epitopes.  We  have  previously
reported a similar decrease in antibody affinity in the fiber
cells, with regard to anti-AQP0 antibody binding [37]. AQP5
is expressed at low levels in both lens epithelial (Figure 5B)
and fiber cells (Figure 5D,E) compared to AQP1 (Figure 5A)
and AQP0 (Figure 5F) in the respective cells types. Epithelial
and fiber cells in the equatorial region also bound the anti-
AQP5 antibody (Figure 5G); the window in Figure 5G is
enlarged (Figure 5H) to show the immunoreactivity to the
fiber cells. As expected, the equatorial (Figure 5I) and anterior
(Figure 5J) regions of the AQP5-KO mouse lens sections
showed no antibody binding.
It is estimated that AQP0 constitutes ~44.8% of the total
lens fiber cell membrane protein in contrast to AQP5 that
constitutes  only  ~0.36%  [24].  In  mammalian  lens,  AQP0
contributes ~80% of the water permeability [4,36,46] in the
lens fiber cells even though it is >40-fold less efficient than
AQP1 [47]. Mouse lens fiber cell lipid contributes only ~1.5%
of the membrane water permeability due to the high levels of
cholesterol and sphingomyelin [4,46,48]. We speculated [4]
that  ~18.5%  of  the  fiber  cell  water  permeability  may  be
contributed by the co-transporters. The present study suggests
that the 18.5% water permeability could come from AQP5
itself, or in combination with the membrane co-transporters.
Lately, passage of water through fiber cell gap junctions has
been postulated [49]. Even though, the expression level is
~100  fold  less  than  AQP0  [24],  the  single  channel  water
permeability of AQP5 is ~20 fold higher [50]. However, in
the  AQP0  knockout  mice,  the  compensatory  water
permeability wielded by AQP5 appears insufficient since the
animals  developed  cataract.  In  addition,  the  cell-to-cell
adhesion  capability  could  be  unique  to  AQP0;
crystallographic  structural  data  [51]  do  not  support  the
possibility of such a function for AQP5. In the WT, AQP5
could be complementing the water permeability needs of the
fiber  cells  along  with  AQP0.  Any  additional  function  for
AQP5 other than water permeability remains unclear. Lack of
AQP1 in the lens epithelial cells of human [52] or mouse
[53] did not cause lens abnormalities, opacity or cataract.
However, AQP1 knockout mouse lenses subjected to stressful
conditions, developed lens opacity/cataract with in vitro and
in vivo models [53]. Under normal conditions, AQP5 present
in  the  epithelial  cells  may  fulfill  the  water  permeability
function in the AQP1 knockout lens, but apparently not under
stressful conditions. Despite the nonoccurrence of phenotypes
(based on the gross lens morphology) due to the absence of
AQP5 in the knockout mouse, it cannot be ruled out that the
function/s of AQP5 could be irrelevant, until more details
emerge from a wide range of studies including the structural
and functional aspects of this protein.
In the lens, while AQP1 is present in the epithelial cells
and AQP0 is present in the fiber cells, AQP5 has a global
expression.  It  is  reasonable  to  speculate  that  the  highly
efficient AQP5 water channel may aid in maintaining lens
transparency  and  homeostasis.  Using  AQP0,  AQP1  and
AQP5-KO mouse models, currently we are investigating the
role  of  AQP5  in  maintaining  lens  transparency  and
homeostasis.
Regulation of AQP5 localization: Several investigators have
demonstrated that AQP5 expression, intracellular trafficking
and localization in the epithelial cells are regulated by cAMP
through the PKA pathway [54-56]. In our in vitro studies,
plasma  membrane  localization  of  AQP5  decreased
significantly  when  MDCK  cells  expressing  mouse  AQP5
were exposed to mp-cAMP (100 μM), a PKA agonist, for 30
min (Figure 6A). On the contrary, when the cells were exposed
to a PKA antagonist, H-89 (20 μM) for the same duration,
there was increase in AQP5 plasma membrane localization
and abundance (Figure 6B). Cells that were incubated first
with the PKA inhibitor H-89 for 30 min and then stimulated
with mp-cAMP for 30 min, did not show significant AQP5
internalization (Figure 6C) as opposed to cells exposed only
to mp-cAMP (Figure 6A). Similarly, in ex-vivo experiments,
plasma  membrane  localization  of  AQP5  decreased
significantly when WT corneas were exposed to mp-cAMP
(100 μM) for 30 min or 6 h (Figure 6D,E). When corneas were
exposed to the PKA inhibitor, H-89 (20 μM) for 30 min or 6
h there was increase in AQP5 plasma membrane localization
and abundance (Figure 6F,G) depending upon the extent of
exposure.
AQP5 has several potential phosphorylation sites (Figure
1).  Two  consensus  PKA/PKG-activated  phosphorylation
Molecular Vision 2012; 18:957-967 <http://www.molvis.org/molvis/v18/a100> © 2012 Molecular Vision
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at 256–259, in loop D and at the COOH-terminal domain,
respectively. Sidhaye et al. [55] had shown cAMP-induced
biphasic  effect  on  AQP5  expression  and  membrane
localization when cells expressing AQP5 were exposed to
cAMP for short and long-terms. AQP5 protein internalization,
lysosomal degradation and a subsequent decrease in AQP5
protein  in  the  plasma  membrane  occurred  in  mouse  lung
epithelial cells exposed to cAMP for a short-term, but long-
term exposure resulted in increased abundance and an increase
in trafficking of AQP5 to the plasma membrane. Expression
and localization of AQP5 in mouse lung epithelial cell line
(MLE-12)  were  regulated  at  transcriptional  and
posttranscriptional  levels,  respectively  [54].  Recently,
Hasegawa et al. [56] reported that AQP5 is phosphorylated at
Thr259  by  PKA  through  cAMP.  Based  on  the  current
investigation  and  previous  studies,  we  hypothesize  that
dynamic  regulation  of  AQP5  expression  and  localization
through PKA pathway could be a potential tool for short and
long-term regulation of membrane water permeability in the
cornea and lens. During aging, when most of the lens proteins
including  aquaporins  undergo  modifications  leading  to
alterations and/or loss of function, increasing the availability
of  AQP5  water  channels  in  the  plasma  membrane  by
dephosphorylating the AQP5 present in the sub-cellular pool
using  small  molecular  pharmacological  compound/drugs
could augment membrane water permeability to maintain lens
microcirculation and homeostasis. Further investigation of
this  regulatory  pathway  may  provide  a  strong  base  for
developing  novel  therapeutic  drug  targets  to  treat  corneal
diseases and lens cataracts.
In conclusion, we have defined the spatial distribution
pattern of AQP5 in the cornea and lens. In the cornea, AQP5
is expressed in the stromal keratocytes in low levels compared
to the epithelial layer. In the lens, AQP5 is expressed in the
epithelial and fiber cells. AQP5 may play a significant role in
maintaining transparency and homeostasis in the avascular
cornea and lens. A thorough understanding of the functional
complementation or uniqueness of the corneal and lens AQPs
will  facilitate  development  of  therapeutic  intervention
strategies to avert pathological corneal swelling and opacity,
as well as age-onset lens opacity and cataract.
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